Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) [Phase 4]
Phase 4 clinical trial update (The SPICY Study) assessing the effectiveness of combined medication for aggression in children with ADHD; the…
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Neuroimaging of the Effects of Concerta in the Treatment of ADHD [Phase 4]
Phase 4 neuroimaging study evaluating the effects of Concerta in treating attention-deficit/hyperactivity disorder, with results posted in 2…
-
FDA approval · 2012-07-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the original application for methylphenidate hydrochloride (LA) from Teva Pharmaceuticals USA, Inc. as a long-acting generic st…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 clinical trial investigating autonomic correlates of impulsivity in preschool children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Atomoxetine Pilot Study in Preschool Children With ADHD [Phase 4]
This document reports the completion of a Phase 4 pilot trial evaluating atomoxetine for attention deficit hyperactivity disorder in prescho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2012-07-05FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) from Eli Lilly and Company, updating labeling.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Methylphenidate Study in Young Children With Developmental Disorders [Phase 4]
Phase 4 trial of methylphenidate in young children with developmental disorders (ADHD) has completed.
-
CLINICAL_TRIALS research · 2012-07-02Clinical Trial Update: Evaluation of Oral Needs of Children With Disorder Attention Deficit/Hyperactivity Disorder
Clinical trial update evaluating the oral care needs of children with attention-deficit/hyperactivity disorder (ADHD).
-
FDA approval · 2012-06-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic combination of four amphetamine salt components under an Original Application (ANDA) for ADHD and narc…
-
CLINICAL_TRIALS research · 2012-06-19Clinical Trial Update: Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders [NA]
Clinical trial update regarding the use of transcranial magnetic stimulation to treat Attention-Deficit/Hyperactivity Disorder; the current …
-
FDA approval · 2012-06-14FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA page describes a supplemental application for Strattera (atomoxetine hydrochloride) by Eli Lilly. The submission status is AP.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD [NA]
Completed clinical trial evaluating whether individualizing Daytrana wear-times improves sleep in children with ADHD; results were posted in…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS [Phase 4]
Open-label Phase 4 pilot study of memantine (Namenda) in adults with ADHD and ADHD NOS has completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents [Phase 4]
A Phase 4 clinical trial in children and adolescents with attention-deficit/hyperactivity disorder sponsored by Eli Lilly was terminated; re…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
This clinical trial update assesses the safety and metabolic profile of lisdexamfetamine (Vyvanse) for treating attention-deficit/hyperactiv…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
The study examined whether educational information influences how women with ADHD accept treatment, and the trial has completed.
-
CLINICAL_TRIALS research · 2012-05-23Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts [Phase 2]
This entry reports a Phase 2 clinical trial evaluating repetitive transcranial magnetic stimulation for symptoms of attention-deficit/hypera…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
A completed follow-up clinical trial evaluating adherence and long-term effects of OROS methylphenidate (CONCERTA) in attention-deficit/hype…
-
CLINICAL_TRIALS research · 2012-05-17Clinical Trial Update: Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
A completed clinical trial evaluating screening for ADHD in adolescent and adult high-risk populations. The update notes completion but does…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
A completed study from Massachusetts General Hospital analyzed family risk of substance use in youth with attention-deficit/hyperactivity di…
-
FDA approval · 2012-05-02FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR by Sandoz Inc (dexmethylphenidate hydrochloride). The submission status indicates app…
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL [Phase 4]
A Phase 4 trial of atomoxetine in children with acquired attentional disorders after ALL chemotherapy has been terminated; the study status …
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 results for metadoxine extended-release in attention-deficit/hyperactivity disorder (ADHD) are reported, describing efficacy and saf…
-
CLINICAL_TRIALS withdrawal · 2012-04-18Clinical Trial Update: Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD
A withdrawn clinical trial assessing how the Quotient ADHD system reports concordance with teacher and parent assessments for ADHD symptoms.
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Atomoxetine Treatment for ADHD and Marijuana Dependence [Phase 2]
Phase 2 results from a clinical trial evaluating atomoxetine for people with ADHD and cannabis use disorder have been posted.